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This is the first demonstration of neuro­
myotonia in a genetically engineered animal 
model of a hereditary neuropathy with a 
defined gene defect. Our finding may eventu­
ally help to define the pathogenesis and mode 
of treatment of hereditary forms of human 
neuromyotonia.
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Anaphylactoid reaction to intravenous 
nnethylpredmsolone in a patient with 
multiple sclerosis
Exacerbations in multiple sclerosis are 
treated with short courses of high dose 
intravenous methylprednisolone. Treaunent 
with intravenous methylprednisolone has 
mainly minor side effects such as transient 
flushing, a brief disturbance of taste, insom- 
niai and mild weight gain.1 An anaphylactoid 
reaction after intravenous methylpred­
nisolone treatment has been described in only 
one patient with multiple sclerosis.2 We 
report on a patient with multiple sclerosis 
who developed an anaphylactoid reaction on 
high dose intravenous methylprednisolone 
treatment. Additional investigations were 
performed to elucidate the mechanism of this 
reaction to intravenous methylprednisolone.
A 44 year old woman was admitted to our 
clinic because of progressive multiple sclero­
sis. One year before admission she had devel­
oped paresis of the legs, and subsequently of 
the arms. She became incontinent for urine 
and faeces. On admission she also com­
plained of numb feelings and muscle cramps 
in her legs. T he medical history mentioned 
hypertension for which she used propranolol 
and hydrochlorothiazide. The family history 
was negative for multiple sclerosis. On 
examination there was vertical nystagmus, 
slight paresis of the arms, paraplegia, incoor­
dination of the arms, and loss of sensation 
from a mid-thoracic level. The tendon 
reflexes of the legs were very brisk, and both 
plantar responses were extensor. Examin­
ation of CSF showed eight white cells/mm1 
(all lymphocytes), and an intrathecal produc­
tion of IgG and IgM. Brain MRI and the cer­
vical part of the spinal cord showed multiple 
white matter lesions. Additional investiga­
tions excluded other diseases—for example, 
borreliosis and lupus erythematosus. A 10 
day treatment with daily administration of 
1000 mg intravenous methylprednisolone 
was started, Methylprednisolone was given in 
its injectable form, methylprednisolone so­
dium succinate, which hydrolyses to methyl- 
prednisolone in the body. The infusion 
period was one hour. Because of cystitis she 
also received trimethoprim. One day after the 
intravenous methylprednisolone course had 
ended, the patient developed generalised 
urticaria which disappeared after a few days, 
and which could have been induced by either 
drug. After informed consent of the patient it 
was decided to give another course, as the 
intravenous methylprednisolone course im­
proved her multiple sclerosis. To guarantee 
minimal risk, we gave 1000 mg intravenous 
methylprednisolone under close monitoring. 
After the first infusion there was a reactiva­
tion of the skin rash, and difficulty with swal­
lowing and breathing, suspicious of an- 
gioedema. Clemastine was given 
intravenously, after which the symptoms 
immediately resolved. Because of clinical 
improvement, therapy was continued with a 
1000 mg dose of intravenous methylpred­
nisolone divided into two, again under close 
monitoring. No symptoms developed. The 
next day we gave die full 1000 mg dose after 
which the patient developed dyspnoea. We 
waited two days and reintroduced 
intravenous methylprednisolone dierapy in 
divided doses. After the second dose the 
patient again became short of breath, needing 
4.0 mg intravenous clemastine. We decided 
to give the patient the next two doses of 500 
mg intravenous methylprednisolone followed 
by 4.0 mg intravenous clemastine, and no 
symptoms developed.
A skin reaction and histamine release test 
were performed to elucidate the pathogenesis 
of the reactions. Our patient developed a skin 
reaction of 5.5 mm after subcutaneous injec­
tion of methylprednisolone (1.0 ml 5% 
methylprednisolone in isotonic saline). How­
ever, when the same solution was subcutane- 
ously injected in nine healthy volunteers, skin 
reactions appeared with a mean diameter of 8 
mm, ranging from 5.5 to 11.5 mm.
To determine if the patient’s adverse reac­
tions to methylprednisolone were IgE medi­
ated, a blood sample was drawn and depleted 
of erythrocytes. This preparation was used for 
histamine release testing, according to the 
procedure described by Lichtenstein and 
Osier.3 A large amount of methylpred­
nisolone (more than 250 ^g/test) resulted in
basophilic histamine release. However, this 
positive result was also found when leuco­
cytes from two healthy donors were used.
To determine whether high plasma con­
centrations of methylprednisolone might ex­
plain the reactions found, we measured blood 
samples which had been taken during a day of 
intravenous methylprednisolone treatment. 
Reversed phase high performance liquid 
chromatography was used for the analysis of 
methylprednisolone and methylprednisolone 
sodium succinate. Methylprednisolone so­
dium succinate declined with a half life of 20 
minutes leading to mediylprednisolone con­
centrations not exceeding 6.5 mg/1, which is 
less than those measured in patients receiving 
high dose intravenous methylprednisolone 
with, no adverse reactions.4
Reviewing the literature we found only one 
case report of a patient with multiple sclero­
sis who developed an anaphylactoid reaction 
to intravenous methylprednisolone.2 This 
patient had a positive skin test for methyl- 
prednisolone, and a radio allergosorbent test 
(RAST) for IgE antibodies was positive. No 
information regarding the RAST procedure 
was mentioned.
Allergic reactions to oral or intravenously 
administered corticosteroids in patients have 
been found but occur infrequently (0.3% of 
the patients).“5 Risk factors for developing 
allergic reactions after receiving intravenous 
methylprednisolone are asthma and aspirin 
intolerance.*' Our patient had no history of 
astiima or other allergic diseases.
Skin tests have been used to investigate the 
nature of side effects to intravenous 
mediylprednisolone.6 We showed that skin 
tests are unreliable as they also gave positive 
reactions in the healthy volunteers.
The “allergic” reactions are probably not 
based on an IgE mediated allergy, but could 
have been caused by fast administration of 
methylprednisolone leading to high plasma 
concentrations. However, raised concentra­
tions were not found/ The histamine release 
reaction for mediylprednisolone sodium suc­
cinate was not indicative of an IgE mediated 
reaction. The clinical reaction is possibly due 
to a (dose related) toxic effect of methylpred­
nisolone on the basophil granulocytes.
In  conclusion! the clinical symptoms which 
developed during high dose intravenous 
methylprednisolone are rare, but can be dan- 
gerous.Tlierefore3 patients widi multiple scle­
rosis who receive an intravenous methylpred­
nisolone treatment for the first time should be 
carefully monitored. According to this case 
the mechanism of the reaction seems to be 
IgE independent, and may have been induced 
by toxic concentrations of mediylpred- 
nisolone on the basophil granulocytes. Skin 
testing with methylprednisolone is unreliable, 
and should be interpreted with care.
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CORRESPONDENCE
Unilateral auditory hallucinations: ear 
or brain?
Brasic and Perry1 convincingly describe a boy 
with unilateral otopathic auditory hallucina­
tions. However, their literature review is very 
misleading, postulating dubious CNS causes 
for auditory hallucinations other than from a 
hyperactive ear. They also do not cite a 
relevant prior case.
Their paper starts: “Unilateral auditory 
hallucinations.„are associated with contralat­
eral CNS lesions”. Their only supporting ref­
erence is Toulouse (1892), who reviewed four 
adults with neurological disease and unilat­
eral auditory hallucinations, allegedly of cor­
tical origin. These turned out to be anything 
but. One case (Regis, 1881) had voices in his 
left ear aggravated by alcohol, sounds of a bell 
and water in his right, impaired hearing in his 
left ear (thought by Toulouse to be of cortical 
origin!); the 1888 case had bilateral auditory 
hallucinations, worse on the left, abolished by 
blocking off the ear which was full of pus; the 
1890 case, an alcoholic wine merchant, had 
bilateral noises (bells, whistles, rattles  ^ etc) 
which alternated and changed into voices in 
his right ear, but there was no examination of 
his ears or hearing; his 1892 case, also an 
alcoholic wine merchant, heard voices in her 
left ear, and had bilateral deafness from 
chronic otitis media. Whatever other lesions 
these four patients had, there were peripheral 
lesions sufficient to trigger tinnitus and audi­
tory hallucinations, although in alcoholic 
patients these can probably be triggered from 
ears with relatively normal hearing.2 By con­
trast with these totally unconvincing cases of 
non-otological cortical origin, Toulouse re­
viewed seven cases of unilateral auditory hal­
lucinations from homolateral ear disease, four 
of which were particularly convincing as the 
auditory hallucinations vanished (three 
cases) or waned (one case) with effective ear 
treatment. Toulouse also noted cases with 
quite different auditory hallucinations in 
opposite ears simultaneously; if of cortical 
origin, a quite implausible degree of func­
tional hemispheric independence is shown.
Their next three references supposedly 
show that auditory hallucinations are caused 
by stimulatory phenomena in the CNS— 
namely, epilepsy (Keshavan et al} 1992), 
schizophrenia (Silbersweig et al} 1995), and
drugs (Ketter et al, 1996).
Keshavan et al reviewed musical hallucina­
tions. In epilepsy, they noted six cases from 
Hecaen and Ropert in whom music occurred 
as part of an epileptic aura, four of whom had 
concomitant ear disease; three case reports 
without structural brain lesions, two with 
pronounced deafness, the third with attacks 
of nausea and rotatory vertigo but no 
otological investigations; three of Penfleld’s 
cases with brain tumours but no ear or hear­
ing examination. In one of these last three, 
seizures were of a “new and curious type*, 
including deafness, unilateral voices, and 
music, starting two years after tumour 
removal. Far from implicating the brain, this 
review of musical hallucinations strongly 
implicates the ear. Even if epileptic patients 
are not known to have ear disease, this should 
be suspected, as Jackson and Gowers estab­
lished last century that epilepsy can arise
from the ear.
In their PET study on hallucinating 
schizophrenic patients, Silbersweig et al 
found increased blood flow in the thalamus 
and not the neocortex. This is not evidence 
that auditory hallucinations are generated in 
the brain; instead, it is consistent with 
peripheral impulses funnelling up via the tha­
lamus.
The volunteers of Ketter et al “consistently 
(29 out of 32 subjects) reported procaine 
induced auditory hallucinations (unformed 
buzzing, ringing, or electronic sounds)”. 
They considered procaine a selective limbic 
activator, even though no change in cerebral 
blood flow corresponded to the “auditory 
hallucinations”. In an ear, nosej and throat 
clinic the above noises would definitely be 
labelled tinnitus, and an obvious peripheral 
cause usually found. In line with this, 
procaine causes cochlear hyperactivation (in­
creased wave I and II amplitude in dogs)3; in 
view of the link between epilepsy and the ear, 
it is noteworthy that the EEG changed from 
an awake pattern to seizure activity.
Thel968 review of sensory deprivation by 
Petrella et al was cited as an example of audi­
tory hallucinations from sensory disinhibiton.
I reviewed some of this literature/ concluding 
that for musical hallucinations there is as 
much evidence for ear disease and labyrin­
thine hyperactivity as when they occur in all 
other conditions and diseases. Deprivation is 
a misnomer; in many experimental situations 
white noise is used to mask environmental 
sounds, whereas if all background noises are 
reduced, normal subjects will start to have 
tinnitus. I recently tested a 16 year old 
dyslexic patient who had never known silence 
(“silence has a permanent noise running 
through it”), yet had never complained of 
tinnitus. Sensory depravation is more likely 
than deprivation, as in fact misprinted!1
A similar case to that of Brasic and Perry1 
throws considerable light on pathophysiologi­
cal processes involved. Both were tormented 
by voices of devils while having symptoms of 
unilateral ear disease; saw devils and animals 
interchanging; had fiery visions (fire sur­
rounded by cockroaches, devil transforming 
into burning wisp of straw); possible fluid in 
one middle ear (blocked grommet plus 
air-bone gap; filthy discharge from one ear). 
Conspicuously omitted1 was any mention of 
tinnitus, the most likely generator of the
auditory hallucinations. Fortunately, the 
other case was Martin Luther/ who clearly
described ringing in his ears, unendurable 
buzzing, thundering, cracks, thumps, etc 
Once, he had a musical hallucination (bells of 
specific churches) while awake in bed be­
cause of noises in his head. Curiously, Luther 
did not have a simple demonic or religious 
explanation for his torments. Instead he 
blamed Satan for his Meniere’s symptoms 
(headache, episodic vertigo, tinnitus), which 
in turn he recognised caused his hallucina­
tions. In fact his symptoms were typical of 
otosyphilis, and there was good evidence that 
he had “French disease”.
If Brasic and Perry still assert a CNS origin 
for auditory hallucinations they need an 
original case report, not reviews or secondary 
sources. Repeated appeals for non-otological 
neurological musical hallucinations have 
failed5 (suggested cases with brainstem le­
sions were also deaf)- I would now like to 
broaden the challenge to cover auditory
v
hallucinations as well. Unless someone can 
come up quickly with a case of auditory hal­
lucination due to a clear neurological lesion 
in someone with normal ears and hearing, the 
only proved cause of auditory hallucinations 
is otological.
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Brasic and Perry reply:
Gordon conjectures that otological pathology 
is the necessary and sufficient condition for 
auditory hallucinations. We disagree. We 
hypothesise that auditory hallucinations have 
many aetiologies which can be classified as 
otological, neurological, neuropsychiatrie, 
and combined. Auditory hallucinations may 
result from the multiple effects of otopathol- 
ogy, such as altered signal transduction in 
hair cells.1 For example, in response to mini­
mal environmental stimuli, diseased cochlear 
hair cells may generate random frequencies
 ^ ^
producing white noise perceived as tinnitus in 
some persons. Auditory hallucinations nW 
also result from neurological illnesses/ in­
cluding after right temporal lobectomy for 
intracerebral hemorrhage without seizures, 
We are preparing a manuscript concerning 
auditory hallucinations in neurological disor­
ders. Auditory hallucinations due to neu­
ropsychiatrie disorders are being studiedj 
particularly in schizophrenia. On functional 
MRI5 two patients with schizophrenia experi­
encing auditory hallucinations showed re­
duced responses of the temporal cortex to 
external auditory stimuli. Therefore, auditory 
hallucinations in some patients with schizo­
phrenia may correspond  with maximal acti­
vation of the  auditory association cortex. 
The physiology of thinking in words was 
assessed utilising PET in six persons wi 
schizophrenia who experienced auditory a ' 
lucinations, six persons with schizophrenia
